NEW YORK STEM CELL FOUND INC has a total of 50 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are HENAN YINFENG BIOLOGICAL ENGINEERING TECH CO LTD, PLASTICELL LTD and LONZA WALKERSVILLE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | EPO (European Patent Office) | 12 | |
#3 | WIPO (World Intellectual Property Organization) | 9 | |
#4 | Canada | 7 | |
#5 | Republic of Korea | 4 | |
#6 | China | 2 | |
#7 | Brazil | 1 | |
#8 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Chemical engineering | |
#6 | Mechanical elements |
# | Name | Total Patents |
---|---|---|
#1 | Noggle Scott | 19 |
#2 | Chang Stephen | 13 |
#3 | Fossati Valentina | 9 |
#4 | Egli Dietrich M | 9 |
#5 | Douvaras Panagiotis | 8 |
#6 | Sladkova Martina | 6 |
#7 | Benvenisty Nissim | 6 |
#8 | Sagi Ido | 6 |
#9 | Parmar Malin | 5 |
#10 | Eggan Kevin | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021072302A1 | Modified stem cells and methods of use thereof | |
WO2021067797A1 | Imaging system and method of use thereof | |
WO2020243618A1 | Functional astrocytes derived from pluripotent stem cells and methods of making and using the same | |
KR20200022383A | system | |
CA3044251A1 | Microfluidic system and method of use thereof | |
WO2018031800A1 | Surface functionalized implant and method of generating the same | |
CA3016575A1 | Microglia derived from pluripotent stem cells and methods of making and using the same | |
EP3328993A1 | Haploid human embryonic stem cell lines and somatic cell lines and methods of making the same | |
EP3013941A1 | Improved systems and methods for producing stem cells and differentiated cells | |
US2015166964A1 | Systems and methods for producing stem cells and differentiated cells | |
KR20190124326A | Automated system for producing induced pluripotent stem cells or differentiated cells |